Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychiatr Serv 56:1270-1273, October 2005
doi: 10.1176/appi.ps.56.10.1270
© 2005 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by McGovern, M. P.
* Articles by Drake, R. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by McGovern, M. P.
* Articles by Drake, R. E.
Related Collections
* Chronically Mentally Ill Patients
* Dual Diagnosis Patients
* Other Psychiatric Rehabilitation
* Addictive Disorders (General)

Special Section on Relapse Prevention: Relapse of Substance Use Disorder and Its Prevention Among Persons With Co-occurring Disorders

Mark P. McGovern, Ph.D., Bonnie R. Wrisley, B.A. and Robert E. Drake, Ph.D.

This article summarizes the scientific literature on the relapse process, describes the basic principles of relapse prevention treatment, highlights the major empirical studies, and offers suggestions for future research and application, especially in terms of ongoing care for persons with co-occurring disorders. Relapse prevention treatments have a well-established efficacy and effectiveness for persons with substance use disorders. Key ingredients include reducing exposure to substances, fostering motivation for abstinence, self-monitoring, recognizing and coping with cravings and negative affect, identifying thought processes with relapse potential, and deploying, if necessary, a crisis plan. Relapse prevention approaches may be best suited for persons in the action of maintenance stages of treatment or recovery. Further research is needed to examine relapse prevention therapies as a key component to continuing care for persons with co-occurring substance use and psychiatric disorders.




This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
R. E. Clark, M. Samnaliev, and M. P. McGovern
Treatment for Co-occurring Mental and Substance Use Disorders in Five State Medicaid Programs
Psychiatr Serv, July 1, 2007; 58(7): 942 - 948.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
A. L. Rollins, S. J. O'Neill, K. E. Davis, and T. S. Devitt
Special Section on Relapse Prevention: Substance Abuse Relapse and Factors Associated With Relapse in an Inner-City Sample of Patients With Dual Diagnoses
Psychiatr Serv, October 1, 2005; 56(10): 1274 - 1281.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
R. E. Drake, M. A. Wallach, and M. P. McGovern
Special Section on Relapse Prevention: Future Directions in Preventing Relapse to Substance Abuse Among Clients With Severe Mental Illnesses
Psychiatr Serv, October 1, 2005; 56(10): 1297 - 1302.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org